Ledger.Open graph →
SEC Form D · filed November 7, 2017

Hoth Therapeutics, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robb Knie · New York, NYExec · Director · PromoterVadim Mats · New York, NYDirectorAnthony Hayes · New York, NYDirectorKenneth Rice · New York, NYDirectorTroy Dayton · Boulder, CODirectorRobert Grant · Denver, COExec · Director · PromoterMark Nottoli · Boulder, CODirectorCole Winans · Denver, CODirectorSantiago D. Suarez Florez · USAQUEN, BOGATA, MauritiusDirectorChristopher D. Reid · USAQUEN, BOGATA, MauritiusExec · Director · PromoterFelipe D. De La Vega Vargara · USAQUEN, BOGATA, MauritiusDirectorPromus Equity Partners, LLC · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗